Eko Devices
Private Company
Funding information not available
Overview
Eko Devices is a private, commercial-stage medical device company founded in 2013 and headquartered in Oakland, California. It has successfully transitioned from a hardware innovator to an integrated AI-driven diagnostics platform, selling over 700,000 devices and securing nine FDA clearances. The company's core value proposition is increasing the accuracy and early detection of cardiovascular and pulmonary diseases by augmenting the traditional stethoscope exam with digital audio, visualization, and real-time AI analysis. Recent milestones include CMS reimbursement for its SENSORA® platform and validation in numerous clinical studies.
Technology Platform
Integrated platform combining digital stethoscope hardware (with enhanced audio and noise cancellation), visualization software (waveforms, 3-lead ECG), and FDA-cleared AI algorithms for real-time detection of cardiac conditions (murmurs, AFib, low ejection fraction). Supports telehealth integration and longitudinal data tracking.
Opportunities
Risk Factors
Competitive Landscape
Eko competes with other digital stethoscope makers like 3M's Littmann CORE Digital, as well as broader cardiac diagnostic and monitoring companies (e.g., AliveCor, Butterfly Network). Its key differentiator is the deep integration of FDA-cleared, real-time AI analysis for specific pathologies directly into the auscultation workflow, creating a comprehensive decision-support platform rather than just a digital listening device.